JP7650663B2 - 検出方法 - Google Patents

検出方法 Download PDF

Info

Publication number
JP7650663B2
JP7650663B2 JP2020567097A JP2020567097A JP7650663B2 JP 7650663 B2 JP7650663 B2 JP 7650663B2 JP 2020567097 A JP2020567097 A JP 2020567097A JP 2020567097 A JP2020567097 A JP 2020567097A JP 7650663 B2 JP7650663 B2 JP 7650663B2
Authority
JP
Japan
Prior art keywords
stool
subject
biomarkers
nucleic acid
rna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020567097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526375A (ja
JPWO2019232483A5 (https=
JP2021526375A5 (https=
Inventor
アンドリュー バーネル
エリカ バーネル
イミン カン
エリザベス ヴュルツラー
ケイティ キャンベル
Original Assignee
ジェネオスコピー インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネオスコピー インコーポレイテッド filed Critical ジェネオスコピー インコーポレイテッド
Publication of JP2021526375A publication Critical patent/JP2021526375A/ja
Publication of JPWO2019232483A5 publication Critical patent/JPWO2019232483A5/ja
Publication of JP2021526375A5 publication Critical patent/JP2021526375A5/ja
Application granted granted Critical
Publication of JP7650663B2 publication Critical patent/JP7650663B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2020567097A 2018-06-01 2019-05-31 検出方法 Active JP7650663B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862679621P 2018-06-01 2018-06-01
US62/679,621 2018-06-01
US201962797763P 2019-01-28 2019-01-28
US62/797,763 2019-01-28
PCT/US2019/035061 WO2019232483A1 (en) 2018-06-01 2019-05-31 Detection method

Publications (4)

Publication Number Publication Date
JP2021526375A JP2021526375A (ja) 2021-10-07
JPWO2019232483A5 JPWO2019232483A5 (https=) 2022-06-01
JP2021526375A5 JP2021526375A5 (https=) 2022-06-01
JP7650663B2 true JP7650663B2 (ja) 2025-03-25

Family

ID=68698469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567097A Active JP7650663B2 (ja) 2018-06-01 2019-05-31 検出方法

Country Status (8)

Country Link
US (3) US20210214797A1 (https=)
EP (1) EP3802885A4 (https=)
JP (1) JP7650663B2 (https=)
CN (1) CN112567050A (https=)
AU (1) AU2019276577B2 (https=)
CA (1) CA3136405A1 (https=)
IL (1) IL279125B2 (https=)
WO (1) WO2019232483A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2986412T3 (es) 2016-10-27 2024-11-11 Geneoscopy Inc Método de aislamiento de ácidos nucleicos eucariotas a partir de muestras de heces
EP4426860A4 (en) * 2021-11-01 2025-11-12 Univ Colorado State Res Found DIRECT NON-INVASIVE PROTEOMIC PROFILING USING STOOL SAMPLES FOR THE DIAGNOSIS OF GASTROINTESTINAL DISEASES
KR102425034B1 (ko) * 2021-12-14 2022-07-27 주식회사 에이아이더뉴트리진 표적 바이러스 검출을 위한 페이퍼 멤브레인 기반 현장용 rna 추출 플랫폼
CN115602326A (zh) * 2022-10-21 2023-01-13 中国科学院计算技术研究所（Cn） 一种用于挖掘肿瘤标志物的方法以及肿瘤风险筛查方法
WO2024108271A1 (en) * 2022-11-25 2024-05-30 Denis King Colorectal cancer risk assessment
EP4654960A1 (en) * 2023-01-26 2025-12-03 Mayo Foundation for Medical Education and Research Assessing and treating mammals having polyps
US20260060660A1 (en) 2024-08-30 2026-03-05 Geneoscopy, Inc. Compositions and methods for immunological testing of stool

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100129844A1 (en) 2007-07-19 2010-05-27 Biomerieux Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer
US20100196889A1 (en) 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
US20130296191A1 (en) 2010-12-23 2013-11-07 Paul Roepman Methods and Means for Molecular Classification of Colorectal Cancers
WO2016176446A2 (en) 2015-04-29 2016-11-03 Geneoscopy, Llc Colorectal cancer screening method and device
WO2018081580A1 (en) 2016-10-27 2018-05-03 Geneoscopy, Llc Detection method

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4033820B2 (ja) 2003-07-29 2008-01-16 株式会社日立製作所 細胞回収方法
JP2007175021A (ja) 2005-12-28 2007-07-12 Sysmex Corp 大腸がんのリンパ節転移マーカー
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
WO2007149269A2 (en) 2006-06-12 2007-12-27 Oncomethylome Sciences S.A. Methylation markers for early detection and prognosis of colon cancers
GB0700374D0 (en) * 2007-01-09 2007-02-14 Oncomethylome Sciences S A NDRG family methylation markers
JPWO2008093530A1 (ja) 2007-01-30 2010-05-20 国立大学法人浜松医科大学 大腸癌病期検出方法
WO2009042676A1 (en) 2007-09-24 2009-04-02 University Of South Florida Method for early detection of cancers
EP2287331A4 (en) 2008-05-12 2012-01-25 Olympus Corp PROCESS FOR PROCESSING EXCREMENTS AND CONTAINERS FOR PROCESSING EXCREMENTS
CN102105583A (zh) 2008-07-23 2011-06-22 奥林巴斯株式会社 从粪便试样中回收核酸的方法、核酸分析方法以及粪便试样处理装置
WO2010042903A1 (en) 2008-10-09 2010-04-15 Alfagene Bioscience, Inc Use and identification of biomarkers for gastrointestinal diseases
WO2010053539A2 (en) * 2008-11-05 2010-05-14 The Texas A&M University System Methods for detecting colorectal diseases and disorders
JPWO2010134246A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 核酸含有試料の調製方法
JPWO2010134245A1 (ja) 2009-05-20 2012-11-08 オリンパス株式会社 哺乳細胞由来核酸の回収方法、核酸解析方法、及び採便用キット
AU2012301589A1 (en) * 2011-08-31 2014-02-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of colorectal cancer
KR102175688B1 (ko) 2013-03-27 2020-11-06 제넨테크, 인크. 베타7 인테그린 길항제를 사용하는 위장 염증성 장애의 치료를 평가하기 위한 바이오마커의 사용
CN103324846A (zh) * 2013-06-13 2013-09-25 浙江加州国际纳米技术研究院绍兴分院 结直肠癌症治疗预后生物标记物的筛选方法
US11035006B2 (en) 2013-07-30 2021-06-15 H. Lee Moffitt Cancer Center And Research Institute, Inc. Colorectal cancer recurrence gene expression signature
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100196889A1 (en) 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
US20100129844A1 (en) 2007-07-19 2010-05-27 Biomerieux Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer
US20130296191A1 (en) 2010-12-23 2013-11-07 Paul Roepman Methods and Means for Molecular Classification of Colorectal Cancers
WO2016176446A2 (en) 2015-04-29 2016-11-03 Geneoscopy, Llc Colorectal cancer screening method and device
WO2018081580A1 (en) 2016-10-27 2018-05-03 Geneoscopy, Llc Detection method

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A Stool Multitarget mRNA Assay for the Detection of Colorectal Neoplasms，Colorectal Cancer: Methods and Protocols, Methods in Molecular Biology，2018年01月，vol.1765，Chapter 14 (p.217-227)，DOI: 10.1007/978-1-4939-7765-9_14
ONCOLOGY LETTERS，2017年，Vol.13，p.2459-2464，DOI: 10.3892/ol.2017.5702
Scientific Reports，2016年，Vol.6，36532 (p.1-14)，DOI: 10.1038/srep36532

Also Published As

Publication number Publication date
AU2019276577B2 (en) 2025-09-11
IL279125B1 (en) 2025-11-01
JP2021526375A (ja) 2021-10-07
AU2019276577A1 (en) 2021-01-14
CN112567050A (zh) 2021-03-26
CA3136405A1 (en) 2019-12-05
EP3802885A1 (en) 2021-04-14
WO2019232483A1 (en) 2019-12-05
IL279125B2 (en) 2026-03-01
US20220154291A1 (en) 2022-05-19
EP3802885A4 (en) 2022-03-02
US20240093312A1 (en) 2024-03-21
US20210214797A1 (en) 2021-07-15
IL279125A (en) 2021-01-31
US11479824B2 (en) 2022-10-25

Similar Documents

Publication Publication Date Title
JP7650663B2 (ja) 検出方法
US12577620B2 (en) Nasal epithelium gene expression signature and classifier for the prediction of lung cancer
Vega et al. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers
US20250146084A1 (en) Colorectal cancer screening method and device
US20230203591A1 (en) Detection method using eukaryotic cells
EP3494235A1 (en) Swarm intelligence-enhanced diagnosis and therapy selection for cancer using tumor- educated platelets
Jiang et al. Liver-derived cell-free nucleic acids in plasma: Biology and applications in liquid biopsies
CN104093859A (zh) 多基因生物标志物的鉴定
WO2023109875A1 (en) Biomarkers for colorectal cancer treatment
US20130084241A1 (en) DEVELOPMENT OF miRNA DIAGNOSTICS TOOLS IN BLADDER CANCER
AU2024243779A1 (en) Arrays targeting differentially accessible chromatin regions using quantitative polymerase chain reaction
WO2023284736A1 (en) Biomarkers for colorectal cancer treatment
CA3077798C (en) Method of isolating eukaryotic nucleic acid from a stool sample
Kujala Circulating nucleic acids as biomarkers for recurrent breast cancer
CN118098339A (zh) 标志物在胃癌免疫联合化疗中的应用、检测模型的构建方法和检测装置
CN116515998A (zh) 一种用于肝癌诊断的生物标志物的组合物及其应用

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20210421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210510

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220524

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220524

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230517

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230529

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230815

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20231016

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240115

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240315

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240710

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240930

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241219

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250225

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250312

R150 Certificate of patent or registration of utility model

Ref document number: 7650663

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150